-
Innovation Ranking
NewInnovation Ranking – Leap Therapeutics Inc
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with different types of cancer. The company’s pipeline products include DKN-01. DKN-1 is a monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, prostate cancer and gynecologic cancer. FL-301, a monoclonal antibody that targets Claudin18.2, is being tested in patients with gastric and pancreatic cancer. The company has an agreement with BeiGene Ltd for development rights and...
-
Analyst Opinions
NewAI Compute – How Chips Drive Next Industrial Leap
AI Compute Technology Overview GlobalData's "AI Compute: How Chips Drive Next Industrial Leap," innovation radar report explores the transformative impact of semiconductor chip innovations, particularly AI chips, across various industries such as healthcare, telecom, and energy & utilities. The report illuminates how advanced chips are enhancing computational power, enabling improved analytics, and driving automation. By reshaping industrial processes, these technologies are boosting efficiency and fostering innovation. The “AI Compute” report provides strategic insights to help businesses capitalize on the benefits...
-
Product Insights
NewNet Present Value Model: Leap Therapeutics Inc’s Sirexatamab
Empower your strategies with our Net Present Value Model: Leap Therapeutics Inc's Sirexatamab report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Leaps Rigg Solar PV Park
Leaps Rigg Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned and being developed by OPDE Holding SA. The project is at the permitting stage. Empower your strategies with our Leaps Rigg Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewNet Present Value Model: Leap Therapeutics Inc’s DKN-01
Empower your strategies with our Net Present Value Model: Leap Therapeutics Inc's DKN-01 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.